mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.4 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.4 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |